Bayban’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$15.3K Sell
179
-81
-31% -$7.33K 0.01% 362
2026
Q2
$23.8K Hold
260
– – 0.02% 316
2026
Q1
$22.2K Hold
260
– – 0.02% 329
2025
Q4
$20.5K Buy
+260
New +$20.4K 0.02% 332

Other funds holding CL

Bayban's CL Position: Q3 2026 in Review

Bayban reduced its Colgate-Palmolive (CL) stake by 31% in Q3 2026, selling an estimated $7.33K and leaving 179 shares worth $15.3K. The position accounts for 0.01% of the portfolio, ranked #362.

Bayban first reported a position in CL in Q4 2025 and has held it in 4 quarters since. The position peaked at $23.8K in Q2 2026. 1,965 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • Bayban held 179 shares of Colgate-Palmolive worth $15.3K as of Q3 2026.
  • Bayban sold 81 Colgate-Palmolive shares in Q3 2026, an estimated $7.33K.
  • Colgate-Palmolive made up 0.01% of Bayban's portfolio in Q3 2026, its #362 holding.
  • Bayban first reported a position in Colgate-Palmolive in Q4 2025 and has held it in 4 quarters since.
  • Bayban's Colgate-Palmolive position peaked at $23.8K in Q2 2026.
  • 1,965 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on Bayban's 13F filing for Q3 2026, filed 5 Nov 2026.